Biosimilars

Latest News

Infliximab Biosimilar CT-P13 Provides Consistent Safety, Efficacy Across 4 Diseases
Infliximab Biosimilar CT-P13 Provides Consistent Safety, Efficacy Across 4 Diseases

September 21st 2023

A review of Japan post-marketing data support the biosimilar in use for psoriasis, rheumatoid arthritis, Crohn's disease and ulcerative colitis.

Infliximab Biosimilar Maintains Inflammation Control in Non-Infectious Uveitis
Infliximab Biosimilar Maintains Inflammation Control in Non-Infectious Uveitis

September 21st 2023

Switch from TNF Inhibitors to Biosimilars Provides Consistent Rheumatoid Arthritis Outcomes
Switch from TNF Inhibitors to Biosimilars Provides Consistent Rheumatoid Arthritis Outcomes

September 20th 2023

Thijs Giezen, PharmD, PhD, MSc | Credit: Biosimilars Nederland
Study Details Trends in Retransition, Discontinuation of Infliximab Biosimilars

September 20th 2023

Lower Adalimumab Biosimilar Withdrawal Rates Linked to Gender, Age
Lower Adalimumab Biosimilar Withdrawal Rates Linked to Gender, Age

September 19th 2023

Video Interviews
Podcasts
Screenshot from podcast episode.
Latest CME Events & Activities

Expert Illustrations & Commentaries™: The Role of Radioligand Therapy in mCRPC and How It Could Impact Your Practice in the Future

View More

Onco-Nurse Academy™: Exploring an Advent of Targeted Therapies Across Advanced NSCLC Care and Strategies for Managing Adverse Events Associated With Treatment

View More

Advances in™ Hidradenitis Suppurativa (HS): Optimizing the Management Approach with Available and Emerging Treatments

View More

Clinical ConsultationsTM: Focusing on Fabry Disease in Females: Individualizing Diagnostic and Counseling Plans to Improve Long-Term Outcomes

View More

2022 Annual Psychiatric Times™ World CME Conference™ - Day Three

View More

2022 Annual Psychiatric Times™ World CME Conference™ - Day Two

View More

2022 Annual Psychiatric Times™ World CME Conference™ - Day One

View More

Expert Illustrations & Commentaries™: Exploring the Clinical Rationale for Antagonizing Inflammatory IL-1-beta Signaling in NSCLC

View More

Advances In™: Meeting Unmet Clinical Needs in AML with Evolving Therapeutic Approaches

View More

Bridging the Care Gap in Anemia in CKD: A Comprehensive Guide to Enhancing Patient Care

Register Now!

Community Practice Connections™: Chronic Fibrosing ILDs With Progressive Phenotype–Are You Aware of the Latest Data on Diagnosis and Emerging Treatments?

View More

Catching Them Early: A Real-World Case Discussion on the Application of Testing Methodologies to Identify Key Markers Across NSCLC

View More

Shaping the Management of Multiple Sclerosis – The Potential for BTK Inhibitors in Clinical Practice

View More

Anemia of Chronic Kidney Disease: Improving Recognition and Early Treatment in the Primary Care Setting

View More

Transforming Multiple Sclerosis Care – Clinical Updates on the Effects of BTK Inhibitors

10/13/2023

Register Now!

20th Annual Meeting of the International Society of Gastrointestinal Oncology®

Register Now!

Clinical Consultations: Individualizing Management of Uveitic Macular Edema - Clinical Updates in Treatment Options

View More

Advances In™ Pediatric Neuroblastoma: Exploring Current and Emerging Therapeutic Approaches for Relapsed/Refractory Disease and CNS Metastases

View More

From Clinical Trials to Clinical Practice – Incorporating Screening and Assessment Strategies for the Early Diagnosis of Alzheimer Disease

View More

Taking Pompe Disease Management to the Next Level: Optimizing Clinical Assessments and Treatment Decision-Making

View More

Evaluating the Evolution of CKD Treatment: What’s New and How Can We Incorporate It?

View More

2022 BURST Year in Review™: Reflecting on Recent Evidence for Testing in Patients with GI Cancers

View More

2022 BURST Year in Review™: How Has Recent Evidence in Testing Elevated Outcomes in Patients with Lung Cancers

View More

4th Annual Virtual Tumor Board®: Diagnosis and Management of Polycythemia Vera and Myelofibrosis

View More

Expanding Options Beyond Conventional Therapy in HR+ Breast Cancer to Overcome Unmet Needs

View More

Medical Crossfire®: Experts Address Your Burning Questions on the Evolving Treatment of MF, PV, and ET!

View More

Burst CME: Selecting an Appropriate Influenza Vaccine for Adults 65 Years and Older

View More

Virtual Testing Board: Digging Deeper on Your Testing Reports to Elevate Patient Outcomes in Advanced Non–Small Cell Lung Cancer

View More

Best Practice in the Multidisciplinary Care of the Patient with HS

View More

Addressing Challenges in the Management of HS in Special Populations

View More

More News

© 2023 MJH Life Sciences

All rights reserved.